Alexandria Real Estate Equities Named Most Trustworthy in Life Science Real Estate for Fourth Year
Event summary
- Alexandria Real Estate Equities ranked second most trustworthy in the real estate category by Newsweek for 2026.
- 82% of 2025 leasing activity came from existing tenants, with 53% of rental revenue from investment-grade or large-cap tenants.
- Broke ground on a 466,598 RSF Biomedical Research Center for Novartis in San Diego in February 2026.
- Megacampus ecosystems represent 78% of annual rental revenue as of December 31, 2025.
The big picture
Alexandria's fourth consecutive recognition as a most trustworthy company underscores its strategic advantage in the life science real estate sector. With a market capitalization of $20.75 billion and a focus on high-quality, collaborative ecosystems, the company is well-positioned to capitalize on the growing demand for specialized life science real estate. Its ability to attract and retain top-tier tenants like Novartis highlights the competitive moat of its Megacampus model.
What we're watching
- Tenant Retention
- Whether Alexandria can sustain its high tenant retention rate (82% in 2025) amid potential market shifts.
- Industry Trust
- How the industry's trust in Alexandria's Megacampus platform will impact long-term lease agreements.
- Innovation Hubs
- The pace at which Alexandria can develop and fill new innovation centers like the Novartis facility in San Diego.
Related topics